GE HealthCare’s SOFIE deal deepens a complicated relationship with Lantheus
GE HealthCare’s planned $945m acquisition of SOFIE Biosciences has largely been read as a move to protect supply for Flyrcado,…
Analyst Comment
Boston Scientific recalls spinal cord stimulators
The battle for the community EPR: will technology follow the NHS out of the hospital?
IVL adoption grows, but consistency remains the real test
NHS corrects FDP disclosure over supplier access to identifiable patient data
What will health and social care look like under Andy Burnham?
GLP-1 medications reduced the number of bariatric surgeries
EAN 2026: MS Copilot shows promise in monitoring disability progression in MS
